Table 2.
Animal | Diseaseb | Inoculumc | Reference | S. Blot | PCR |
---|---|---|---|---|---|
O3 | Thymic lymphoma | FeLV-A/61E | Chandhasin et al., 2005 | + | + |
O4 | Thymic lymphoma | FeLV-A/61E | Chandhasin et al., 2005 | + | + |
O5 | Thymic lymphoma | FeLV-A/61E | Chandhasin et al., 2005 | + | + |
O6 | Thymic lymphoma | FeLV-A/61E | Chandhasin et al., 2005 | + | + |
O23 | Thymic lymphoma | 61E945L | Chandhasin et al., 2005 | + | + |
O24 | Thymic lymphoma | 61E945L | Chandhasin et al., 2005 | + | + |
O25 | Thymic lymphoma | 61E945L | Chandhasin et al., 2005 | + | + |
O26 | Thymic lymphoma | 61E945L | Chandhasin et al., 2005 | + | + |
981-2 | Thymic lymphoma | LC-FeLV (FeLV-A+B) | Levy, Fish & Baskin, 1988 | − | − |
981-3 | Thymic lymphoma | LC-FeLV (FeLV-A+B) | Levy, Fish & Baskin, 1988 | + | + |
J5-1 | Thymic lymphoma | LC-FeLV (FeLV-A+B) | Levy, Fish & Baskin, 1988 | − | − |
N65 | Thymic lymphoma | 61E/945SL | Chandhasin et al., 2005 | − | + |
N67 | Thymic lymphoma | 61E/945SL | Chandhasin et al., 2005 | − | + |
N89 | Unknown | 61E/945SL | Chandhasin et al., 2005 | − | ± |
N90 | Multicentric lymphoma | 61E/945SL | Chandhasin et al., 2005 | − | ± |
N91 | Multicentric lymphoma | 61E/945SL | Chandhasin et al., 2005 | − | ± |
N92 | Multicentric lymphoma | 61E/945SL | Chandhasin et al., 2005 | − | ± |
586-4 | Feline infectious peritonitis | FeLV-A+B | Levy, Fish & Baskin, 1988 | + | + |
585-2 | Transient lymphadenopathy | LC-FeLV (FeLV-A+B) | Levy, Fish & Baskin, 1988 | − | + |
586-3 | Healthy | LC-FeLV (FeLV-A+B) | Levy, Fish & Baskin, 1988 | + | + |
586-5 | Healthy | Mock | Levy, Fish & Baskin, 1988 | − | − |
585-1 | Healthy | Mock | Levy, Fish & Baskin, 1988 | − | − |
Presence (+) or absence (−) of FeLV-B proviral DNA as detected by Southern blot analysis or polymerase chain reaction (PCR) amplification. ± = weakly detectable.
Tumor tissues were analyzed from animals with lymphoma. Lymph node was examined from animals 586-3 and 586-4. PBMC were examined from animals 585-1, 585-2 and 586-5. Lung, lymph node and liver was examined from N89.
Animals were inoculated experimentally with FeLV-A/61E, a synthetic recombinant of FeLV-A/61E containing either the LTR of FeLV-945 (61E945L) or the SU gene and LTR of FeLV-945 (61E/945SL), a natural myc-containing isolate of FeLV (LC-FeLV) in the presence of helper viruses FeLV-A and FeLV-B (FeLV A+B), or the helper viruses alone (FeLV-A+B). All animals were inoculated intraperitoneally except N65 and N67, which were inoculated intradermally.